Antipsychotics block muscarinic acetylcholine receptor-mediated cyclic GMP formation in cultured mouse neuroblastoma cells

E. Richelson

Research output: Contribution to journalArticle

20 Scopus citations

Abstract

Antipsychotic drugs (for example, phenothiazines, butyrophenones) have side effects similar to those of atropine, suggesting that they block the muscarinic acetylcholine receptor. Receptor-binding studies with radioactively-labelled ligands have been used to study the muscarinic acetylcholine receptor and to show that antipsychotic drugs vary in their potency at displacing the ligand from binding sites in rat brain homogenates. In all receptor binding studies it is essential to demonstrate that binding data in fact reflect a drug-receptor interaction in a pharmacological sense. These correlations are ideally determined using the same tissue for binding and for biological studies such as was done for certain polypeptide hormone receptors and for the β-adrenergic receptor. For the muscarinic acetylcholine receptor of nervous tissue, however, a direct correlation of binding data with pharmacological data has not been shown. Thus, there remains a question whether the displacement by antipsychotic drugs of a radioactively-labelled muscarinic receptor antagonist from brain homogenates reflects blockade by these drugs of this receptor. We report here that antipsychotic drugs block the muscarinic acetylcholine receptor in cultured nerve cells.

Original languageEnglish (US)
Pages (from-to)371-373
Number of pages3
JournalNature
Volume266
Issue number5600
StatePublished - 1977

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Antipsychotics block muscarinic acetylcholine receptor-mediated cyclic GMP formation in cultured mouse neuroblastoma cells'. Together they form a unique fingerprint.

  • Cite this